Amicus rejiggers gene therapy plans as SPAC merger folds in unfriendly market
The SPAC merger that Amicus Therapeutics planned for its gene therapy assets has been called off due to market conditions. The rare disease company is […]
The SPAC merger that Amicus Therapeutics planned for its gene therapy assets has been called off due to market conditions. The rare disease company is […]
Which capital funding options fit your healthcare or life science business?
The Covid-19 pandemic pushed the already impressive growth in healthcare investing to new heights, with valuations on the rise and companies gaining access to vast […]
Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking at J.P. Morgan, is bullish that the momentum will continue, particularly with […]
Digital health startups raised a record-breaking $6.7 billion in the first quarter of 2021. Large funding rounds propelled them past previous months.
More healthcare startups are choosing to go public through mergers with special-purpose acquisition companies— publicly-traded shell companies created with the purpose of taking a private […]
The tilt was less pronounced in pharma and biotech, which attracted a record level of investment despite the Covid-19 pandemic according to a quarterly report […]
Copyright © 2024 | WordPress Theme by MH Themes